Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
New insights in the clinical and translational relevance of miR483-5p in adrenocortical cancer.
Salvianti F, Canu L, Poli G, Armignacco R, Scatena C, Cantini G, Di Franco A, Gelmini S, Ercolino T, Pazzagli M, Nesi G, Mannelli M, Pinzani P, Luconi M. Salvianti F, et al. Among authors: scatena c. Oncotarget. 2017 Jul 10;8(39):65525-65533. doi: 10.18632/oncotarget.19118. eCollection 2017 Sep 12. Oncotarget. 2017. PMID: 29029450 Free PMC article.
Quality of life and satisfaction of patients after oncoplastic or traditional breast-conserving surgery using the BREAST-Q (BCT module): a prospective study.
Ghilli M, Mariniello MD, Ferrè F, Morganti R, Perre E, Novaro R, Colizzi L, Camilleri V, Baldetti G, Rossetti E, Coletti L, Scatena C, Ghilardi M, Cossu MC, Roncella M. Ghilli M, et al. Among authors: scatena c. Breast Cancer. 2023 Sep;30(5):802-809. doi: 10.1007/s12282-023-01474-1. Epub 2023 Jun 26. Breast Cancer. 2023. PMID: 37358721 Free PMC article.
Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells.
Volinia S, Bertagnolo V, Grassilli S, Brugnoli F, Manfrini M, Galasso M, Scatena C, Mazzanti CM, Lessi F, Naccarato G, Caligo A, Bianchini E, Piubello Q, Orvieto E, Rugge M, Natali C, Reale D, Vecchione A, Warner S, Croce CM, Capitani S. Volinia S, et al. Among authors: scatena c. Oncotarget. 2018 May 4;9(34):23543-23553. doi: 10.18632/oncotarget.25261. eCollection 2018 May 4. Oncotarget. 2018. PMID: 29805754 Free PMC article.
Cancer astrocytes have a more conserved molecular status in long recurrence free survival (RFS) IDH1 wild-type glioblastoma patients: new emerging cancer players.
Franceschi S, Lessi F, Aretini P, Ortenzi V, Scatena C, Menicagli M, La Ferla M, Civita P, Zavaglia K, Scopelliti C, Apollo A, Carbone FG, Vannozzi R, Bevilacqua G, Pasqualetti F, Naccarato AG, Mazzanti CM. Franceschi S, et al. Among authors: scatena c. Oncotarget. 2018 May 8;9(35):24014-24027. doi: 10.18632/oncotarget.25265. eCollection 2018 May 8. Oncotarget. 2018. PMID: 29844869 Free PMC article.
Human saliva as route of inter-human infection for mouse mammary tumor virus.
Mazzanti CM, Lessi F, Armogida I, Zavaglia K, Franceschi S, Al Hamad M, Roncella M, Ghilli M, Boldrini A, Aretini P, Fanelli G, Marchetti I, Scatena C, Hochman J, Naccarato AG, Bevilacqua G. Mazzanti CM, et al. Among authors: scatena c. Oncotarget. 2015 Jul 30;6(21):18355-63. doi: 10.18632/oncotarget.4567. Oncotarget. 2015. PMID: 26214095 Free PMC article.
Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients.
Del Re M, Bertolini I, Crucitta S, Fontanelli L, Rofi E, De Angelis C, Diodati L, Cavallero D, Gianfilippo G, Salvadori B, Fogli S, Falcone A, Scatena C, Naccarato AG, Roncella M, Ghilli M, Morganti R, Fontana A, Danesi R. Del Re M, et al. Among authors: scatena c. Breast Cancer Res Treat. 2019 Nov;178(1):57-62. doi: 10.1007/s10549-019-05365-y. Epub 2019 Jul 26. Breast Cancer Res Treat. 2019. PMID: 31346846
94 results